Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer.

[1]  A. Gazdar,et al.  Apoptosis and lung cancer: A review , 2003, Journal of cellular biochemistry.

[2]  M. Spitz,et al.  γ-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer , 2001 .

[3]  E. Bowman,et al.  Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. , 2001, Cancer research.

[4]  C. Angeletti,et al.  Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer , 2001, Oncogene.

[5]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[6]  J H Hwang,et al.  Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[7]  M. Spitz,et al.  Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. , 2001, Cancer research.

[8]  M. Spitz,et al.  Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. , 2000, Journal of the National Cancer Institute.

[9]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[10]  U. Dianzani,et al.  Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. , 2000, Blood.

[11]  M. Shin,et al.  Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer , 1999, Oncogene.

[12]  N. Manolios,et al.  Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. , 1997, Molecular immunology.

[13]  L. Notarangelo,et al.  Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. , 1997, Blood.

[14]  R. Neta.  Modulation of radiation damage by cytokines , 1997, Stem cells.

[15]  M. Spitz,et al.  Reduced DNA repair capacity in lung cancer patients. , 1996, Cancer research.

[16]  V. Dixit,et al.  Recent advances in tumor necrosis factor and CD40 signaling. , 1996, Current opinion in genetics & development.

[17]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[18]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[19]  I. Behrmann,et al.  Structure of the human APO‐1 gene , 1994, European journal of immunology.

[20]  K. Shuai,et al.  Interferon-activated signal transduction to the nucleus. , 1994, Current opinion in cell biology.

[21]  J. Lotem,et al.  Control of programmed cell death in normal and leukemic cells: new implications for therapy. , 1993, Blood.

[22]  J. Inazawa,et al.  Assignment of the human Fas antigen gene (Fas) to 10q24.1. , 1992, Genomics.

[23]  A. Knudson.  Overview: genes that predispose to cancer. , 1991, Mutation research.

[24]  E. Pollack,et al.  What are the odds that smoking will kill you? , 1987, American journal of public health.

[25]  D. Phillips.  Fifty years of benzo(a)pyrene , 1983, Nature.

[26]  H. Gelboin.  Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[27]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[28]  C. Angeletti,et al.  Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer. , 2002, International journal of oncology.

[29]  P. Shields,et al.  Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  M. Tang,et al.  Interactions of benzo(a)pyrene diol-epoxides with linear and supercoiled DNA. , 1985, Cancer research.